Adè Thompson

• #11 National Rank (2024) with 137% to goal, driven by strategic targeting, clinical education, and disciplined execution.
• Achieved 105% of MBO quota, aligning call strategy tightly with marketing and brand objectives.

• Collaborated cross-functionally across diagnostic-to-infusion pathways to facilitate 24 infusions $4,680,000 aligning multidisciplinary HCPs, infusion centers, and payers to accelerate patient access.

• Awarded Stretching Impact 2025 for outstanding impact and execution

• Improved national territory rank from #83 → #24 (+71% growth) through precision targeting, clinical influence, and structured sales planning.
• Relocated from Austin to Arizona and grew cardiometabolic market share through disciplined targeting and data-driven execution.

• Surpassed $100K quota in under 3 weeks by engaging C-suite decision-makers and diagnosing operational pain points, demonstrating agility, initiative, and consultative selling.
• Consistently reached $100K+ monthly revenue goals, delivering repeat top-tier performance month over month.

• Built and managed a $2,800,000 pipeline, closing three deals in less than six months within a 12-month cycle, showcasing organizational skills and an effective sales strategy.

• Drove SaaS adoption across multispecialty groups, improving access and workflow while achieving $15K in weekly quota attainment.

• Promoted Otezla, Aimovig, and Repatha, and delivered 13% regional growth by optimizing clinical messaging, objection handling, and closing models.

• Generated $1.5M in buy-and-bill revenue in seven months by aligning access initiatives with hospital and orthopedic account needs, identifying and developing business opportunities.

• Grew generic Colchicine +8% and branded products +5%, earning three Top Performer Awards (2018).